Literature DB >> 17397790

Severe malaria in Cameroonian children: correlation between plasma levels of three soluble inducible adhesion molecules and TNF-alpha.

Viviane H M Tchinda1, Armand D Tadem, Ernest A Tako, Gilbert Tene, Josephine Fogako, Philomina Nyonglema, Grace Sama, Ainong Zhou, Rose G F Leke.   

Abstract

Plasma levels of three soluble inducible adhesion molecules, namely: intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1) and endothelial leucocyte adhesion molecule-1 (sELAM-1) or sE-selectin and the pro-inflammatory cytokine, tumour necrosis factor-alpha (TNF-alpha) were measured in well-defined clinical groups of children with severe and uncomplicated malaria. The goal of the study was to investigate the role of these molecules in immunopathogenic processes associated with severe malaria in Cameroonian children. Results showed significantly increased plasma concentrations of sICAM-1, sVCAM-1 and sE-selectin in children with severe malaria compared to those with uncomplicated malaria and healthy children (P<0.001). TNF-alpha levels increased significantly in children with severe malaria, approximately 2-folds compared to those with uncomplicated malaria and about 3-folds compared to healthy children (P<0.001). More importantly, levels of TNF-alpha strongly correlated with those of the three adhesion molecules and were significantly associated with increased risk of death (P=0.03). In addition, children who died from severe malaria showed higher mean levels of all measured factors compared to those who recovered, with significant differences observed with sICAM-1 (P<0.001) and sE-selectin (P=0.002). Furthermore, children with severe malarial anemia relative to those without, showed significantly elevated levels of the three soluble molecules; and sICAM-1 was significantly associated with increased risk of severe anemia. Taken together, these results confirm the role of TNF-alpha and the three adhesion molecules in pathogenic processes associated with severe malaria in children, and suggest an association between sICAM-1 and severe malarial anemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17397790     DOI: 10.1016/j.actatropica.2007.02.011

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  29 in total

1.  TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria.

Authors:  Nadia A Sam-Agudu; Jennifer A Greene; Robert O Opoka; James W Kazura; Michael J Boivin; Peter A Zimmerman; Melissa A Riedesel; Tracy L Bergemann; Lisa A Schimmenti; Chandy C John
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

2.  Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: a retrospective case-control study*.

Authors:  Andrea L Conroy; Simon J Glover; Michael Hawkes; Laura K Erdman; Karl B Seydel; Terrie E Taylor; Malcolm E Molyneux; Kevin C Kain
Journal:  Crit Care Med       Date:  2012-03       Impact factor: 7.598

3.  Distinct Biomarker Profiles Distinguish Malawian Children with Malarial and Non-malarial Sepsis.

Authors:  Teresa B Kortz; James Nyirenda; Dumizulu Tembo; Kristina Elfving; Kimberly Baltzell; Gama Bandawe; Philip J Rosenthal; Sarah B Macfarlane; Wilson Mandala; Tonney S Nyirenda
Journal:  Am J Trop Med Hyg       Date:  2019-12       Impact factor: 2.345

4.  Elevated cerebrospinal fluid tumour necrosis factor is associated with acute and long-term neurocognitive impairment in cerebral malaria.

Authors:  E Shabani; B J Ouma; R Idro; P Bangirana; R O Opoka; G S Park; A L Conroy; C C John
Journal:  Parasite Immunol       Date:  2017-05-28       Impact factor: 2.280

5.  Investigation on Plasmodium falciparum and Plasmodium vivax infection influencing host haematological factors in tribal dominant and malaria endemic population of Jharkhand.

Authors:  Mohammad Mobassir Hussain; Mohammad Sohail; Kumar Abhishek; Mohammad Raziuddin
Journal:  Saudi J Biol Sci       Date:  2013-02-01       Impact factor: 4.219

6.  Similar cytokine responses and degrees of anemia in patients with Plasmodium falciparum and Plasmodium vivax infections in the Brazilian Amazon region.

Authors:  Andréa Aparecida Morais Fernandes; Leonardo José de Moura Carvalho; Graziela Maria Zanini; Ana Maria Revorêdo da Silva Ventura; José Maria Souza; Paulo Marcelo Cotias; Isaac Lima Silva-Filho; Cláudio Tadeu Daniel-Ribeiro
Journal:  Clin Vaccine Immunol       Date:  2008-02-06

7.  Role of polymorphisms of toll-like receptor (TLR) 4, TLR9, toll-interleukin 1 receptor domain containing adaptor protein (TIRAP) and FCGR2A genes in malaria susceptibility and severity in Burundian children.

Authors:  Susanna Esposito; Claudio Giuseppe Molteni; Alberto Zampiero; Elena Baggi; Anna Lavizzari; Margherita Semino; Cristina Daleno; Michela Groppo; Alessia Scala; Leonardo Terranova; Monica Miozzo; Claudio Pelucchi; Nicola Principi
Journal:  Malar J       Date:  2012-06-12       Impact factor: 2.979

8.  Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children.

Authors:  Fiona E Lovegrove; Noppadon Tangpukdee; Robert O Opoka; Erin I Lafferty; Nimerta Rajwans; Michael Hawkes; Srivicha Krudsood; Sornchai Looareesuwan; Chandy C John; W Conrad Liles; Kevin C Kain
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

9.  A longitudinal study on anaemia in children with Plasmodium falciparum infection in the Mount Cameroon region: prevalence, risk factors and perceptions by caregivers.

Authors:  Irene Ule Ngole Sumbele; Moses Samje; Theresa Nkuo-Akenji
Journal:  BMC Infect Dis       Date:  2013-03-05       Impact factor: 3.090

10.  A potential role for plasma uric acid in the endothelial pathology of Plasmodium falciparum malaria.

Authors:  Neida K Mita-Mendoza; Diana L van de Hoef; Tatiana M Lopera-Mesa; Saibou Doumbia; Drissa Konate; Mory Doumbouya; Wenjuan Gu; Jennifer M Anderson; Leopoldo Santos-Argumedo; Ana Rodriguez; Michael P Fay; Mahamadou Diakite; Carole A Long; Rick M Fairhurst
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.